TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 6 | 0 | 46 | 120 | 83 | 119 | 75 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/9/15 18:50 | 4/9/15 | SNGX | Soligenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brownlie Keith L | NJ | D | M.d | 9 | 0.6100 | 0 | 14 | 40 | 50 | D | 18 | -27 | -19 | 54 | 6 | 0 | -4 | -1 | 3 | 18 | 4 | 25 | -31 | -45 | |
5/16/14 07:30 | 5/14/14 | SNGX | Soligenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brownlie Keith L | NJ | D | M.d | 5 | 0.3000 | 0 | 17 | 88 | 36 | D | 485 | 49 | -14 | -1 | -9 | -8 | 1 | 7 | 2 | -7 | 13 | 3 | -8 | -25 | |
6/26/13 16:17 | 6/25/13 | SNGX | Soligenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brownlie Keith L | NJ | D | P.d | 20 | 1.05 | 0 | 19 | New | 19 | D | -76 | 220 | 66 | -27 | -30 | -45 | -40 | -36 | 6 | 0 | 46 | 120 | 83 | 119 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |